Removing Risk Evaluation and Mitigation Strategy (REMS) Categorization on Mifepristone
A 2018 policy resolution calling for the AAFP to engage in efforts to overturn the Risk Evaluation and Mitigation Strategy (REMS) classification on Mifepristone. The resolution was adopted by the 2018 Congress of Delegates.
